A total of 37 payers and providers have now signed on.
AI doctor © Production Perig - stock.adobe.com
Artificial intelligence use in healthcare is on the rise in the United States. To ensure it remains safe, secure and trustworthy, the White House drafted a pledge called the White House Healthcare AI Commitments, originally published on Dec. 14, 2023.
Since then, 37 payers and providers have shown solidarity with the following five official statements:
As of yesterday, Independence Blue Cross (IBX) is the latest organization to add its name to the list.
“Independence Blue Cross continues to lead the way in health care innovation. We are dedicated to advocating for advancements that improve care delivery, user experience, and affordability,” Mike Vennera, executive vice president and chief strategy, development, and information officer for Independence Blue Cross said in a news release. “We’re proud to have a seat at the table, among other policy experts and national thought leaders.”
Other notable names on the list include CVS Health, Tufts Medicine, Boston Children's Hospital, Duke Health, UC Davis Health, Allina Health and Ceders-Sinai.
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Winrevair Reduced Risk of Morbidity and Mortality by 76% in PAH | ACC 2025
March 31st 2025In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension.
Read More
Clopidogrel Beat Aspirin in Preventing Heart Attacks After PCI | ACC 2025
March 31st 2025Clopidogrel monotherapy may be an alternative to aspirin for prevention of cardiac events in high-risk patients after percutaneous coronary intervention, according to a new study presented at ACC 2025.
Read More